Clinical Trial Update: Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED [Phase 2]

View source ↗

Summary

A Phase 2a proof-of-concept study evaluating a topical sildenafil formulation for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Topical sildenafil (sildenafil)

Snippet

Sponsor: Strategic Science & Technologies, LLC | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED